Extrawell Pharmaceutical Holdings Balance Sheet Health
Financial Health criteria checks 3/6
Extrawell Pharmaceutical Holdings has a total shareholder equity of HK$1.1B and total debt of HK$117.1M, which brings its debt-to-equity ratio to 10.5%. Its total assets and total liabilities are HK$1.3B and HK$174.6M respectively.
Key information
10.5%
Debt to equity ratio
HK$117.12m
Debt
| Interest coverage ratio | n/a |
| Cash | HK$95.01m |
| Equity | HK$1.11b |
| Total liabilities | HK$174.58m |
| Total assets | HK$1.29b |
Recent financial health updates
Here's Why Extrawell Pharmaceutical Holdings (HKG:858) Can Afford Some Debt
Mar 18
Extrawell Pharmaceutical Holdings (HKG:858) Is Making Moderate Use Of Debt
Dec 01Is Extrawell Pharmaceutical Holdings (HKG:858) Using Debt Sensibly?
Mar 15Recent updates
Here's Why Extrawell Pharmaceutical Holdings (HKG:858) Can Afford Some Debt
Mar 18Extrawell Pharmaceutical Holdings (HKG:858) Is Making Moderate Use Of Debt
Dec 01We Think That There Are Some Issues For Extrawell Pharmaceutical Holdings (HKG:858) Beyond Its Promising Earnings
Aug 04Is Extrawell Pharmaceutical Holdings (HKG:858) Using Debt Sensibly?
Mar 15Some Shareholders May Object To A Pay Rise For Extrawell Pharmaceutical Holdings Limited's (HKG:858) CEO This Year
Aug 20Financial Position Analysis
Short Term Liabilities: 858's short term assets (HK$177.4M) exceed its short term liabilities (HK$51.4M).
Long Term Liabilities: 858's short term assets (HK$177.4M) exceed its long term liabilities (HK$123.2M).
Debt to Equity History and Analysis
Debt Level: 858's net debt to equity ratio (2%) is considered satisfactory.
Reducing Debt: 858's debt to equity ratio has increased from 4.7% to 10.5% over the past 5 years.
Debt Coverage: 858's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 858's interest payments on its debt are well covered by EBIT.